India's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in ...

School Assembly News Headlines Today July 21: Parliament faced disruptions as opposition demanded discussions on alleged paper leaks. Heavy...

Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individua...

An Indian vaccine candidate, DengiAll, is in its final testing phase. This single-dose shot offers hope against the deadly dengue disease. ...

India's DengiAll vaccine trial is nearing completion. ICMR scientists anticipate enrolling 10,500 participants by October across 20 Indian ...

Takeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological ...

India started its inaugural phase 3 clinical trial for the DengiAll dengue vaccine, developed by Panacea Biotec. The trial will include 10,...

The Indian Council of Medical Research (ICMR) and Panacea Biotec have launched the first phase three clinical trial for an indigenous dengu...

An expert committee recommended continuation of phase-II clinical trial of Serum Institute of India's vaccine against dengue after successf...

Takeda Pharmaceuticals' dengue vaccine assumes significance since the first vaccine ever licensed for dengue, developed by French drugmaker...

The Japanese drugmaker plans to scale up the production of its dengue vaccine Qdenga through a partnership with Indian vaccine maker Biolog...

Japanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase it...

Yesterday, the Philippines government ordered an investigation into the immunisation of more than 7.3 lakh children with the company's deng...

Sun Pharma will fund and support further development of the vaccine candidate and existing ICGEB knowhow and patents.

The ICGEB plans a larger vaccine trial on monkeys in America; the full-fledged human trial after that could cost more than Rs 100 crore.

Sanofi Pasteur said Food and Drug Administration of Philippines has granted marketing approval to its Dengvaxia vaccine to be licensed for ...

Country Head, Sanofi Pasteur, Stephan Barth, said dengue is a serious health concern in India, causing a significant but under-reported bur...